Yu Miyakawa

Hepatitis B virus-associated hepatocellular carcinoma with Smc5/6 complex deficiency is susceptible to PARP inhibitors.

M. Otsuka, M. Fujishiro, T. Kishikawa, 2022, Biochemical and biophysical research communications.

Humanized virus-suppressing factor inhibits hepatitis B virus infection by targeting viral cell entry

M. Otsuka, K. Koike, Kazuma Sekiba, 2021, Heliyon.

HBx-induced degradation of Smc5/6 complex impairs homologous recombination-mediated repair of damaged DNA.

A. Ryo, M. Otsuka, K. Koike, 2021, Journal of hepatology.

The fatty-acid amide hydrolase inhibitor URB597 inhibits MICA/B shedding

M. Otsuka, K. Koike, Kazuma Sekiba, 2020, Scientific Reports.

Expression of circular RNA CDR1‑AS in colon cancer cells increases cell surface PD‑L1 protein levels.

M. Otsuka, K. Koike, T. Kishikawa, 2019, Oncology reports.

Smaller extracellular vesicles are released from pancreatic cancer cells by the alteration of the lipid composition under low glucose conditions.

M. Otsuka, M. Fujishiro, T. Kishikawa, 2022, Biochemical and biophysical research communications.

Gut Bacteria-derived Membrane Vesicles Induce Colonic Dysplasia by Inducing DNA Damage in Colon Epithelial Cells

M. Otsuka, T. Kishikawa, Rei Ishibashi, 2024, Cellular and molecular gastroenterology and hepatology.

Satellite double-stranded RNA induces mesenchymal transition in pancreatic cancer by regulating alternative splicing

M. Otsuka, T. Kishikawa, Nariaki Odawara, 2024, The Journal of biological chemistry.

Cabozantinib inhibits HBV-RNA transcription by decreasing STAT3 binding to the enhancer region of cccDNA

M. Otsuka, T. Kishikawa, Kazuma Sekiba, 2023, Hepatology communications.